Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Processa Pharmaceuticals Inc (PCSA)

Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Processa Pharmaceuticals Inc 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 USA

www.processapharmaceuticals.com Employees: 13 P: 443-776-3133 F: 443-288-4420

Description:

Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,973
Enterprise Value, $K -1,737
Shares Outstanding, K 3,267
Annual Sales, $ 0 K
Annual Net Income, $ -11,120 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,380 K
EBIT, $ -11,780 K
EBITDA, $ -10,990 K
60-Month Beta 0.60
% of Insider Shareholders 13.00%
% of Institutional Shareholders 91.93%
Float, K 2,842
% Float 87.00%
Short Volume Ratio 0.79

Growth:

1-Year Return -88.68%
3-Year Return -99.18%
5-Year Return -99.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 39.47%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.03 on 10/30/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -3.39
EPS Growth vs. Prev Qtr -1.98%
EPS Growth vs. Prev Year 35.63%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/22/24

PCSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -195.22%
Return-on-Assets % -163.06%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.79
Book Value/Share 1.14
Interest Coverage -0.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar